Skip to main content

People in the News: Mar 6, 2009

NEW YORK (GenomeWeb News) - William Moffitt has agreed to stay on as president and CEO at Nanosphere for a three-year term, the company said in a filing with the US Securities and Exchange Commission this week. Under the agreement, Moffitt will receive a salary of $427,000 and bonuses that could be as much as 60 percent of his salary, and in 2010 and 2011 his bonus will not be less than $150,000.


Agendia has tapped Al Luderer to serve on its supervisory board. Luderer is CEO of BioTrove, and he is on the scientific advisory board at Washington University's Department of Biomedical Engineering. He formerly was CEO of Light Sciences Corporation, and he has been COO at BioMerieux. He also previously served as VP of technology development and support at Boehringer Mannheim.


Flourotechnics has appointed James Walker to take over the CEO job from Duncan Veal, who will step down to take over the post of chief technology officer. Walker has been company chief financial and operations officer since 2002, and before that he was CFO at the Hotel Dynamics Group.


Bioinformatics researcher Cathy Wu has been named the Edward G. Jefferson Chair of Bioinformatics and Computational Biology at the University of Delaware. In the job, she will serve in the Department of Computer and Information Sciences, the Department of Biological Sciences, and the Delaware Biotechnology Institute. Wu will retain her adjunct status as a professor at Georgetown University Medical Center.


Genetic Alliance has named Susan King, who is an ordained interfaith minister specializing in connections between the life sciences and society, to serve on the Genetic Alliance Council. King currently is associate director for the Life Science and Society program at the University of Michigan, and she is a member of the Genetics Equity Network and the American Public Health Genomics Forum.


BG Medicine has named Doug White to be executive VP and general manager. White has previously been a senior VP of sales and marketing at Qiagen, and he has worked at Digene, Bayer, Chiron Diagnostics, and Abbott Laboratories.


Mort Minaee has taken the post of head of regulatory affairs at 454 Life Sciences, part of Roche. Minaee formerly was director of regulatory and clinical affairs at Abbott Molecular Diagnostics, and he also previously worked with Siemens Medical Solutions.


Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People in the News, a weekly roundup of industry comings and goings.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.